ProShare Advisors’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-16,603
Closed -$871K 2119
2020
Q3
$871K Sell
16,603
-20,186
-55% -$1.06M ﹤0.01% 763
2020
Q2
$1.22M Buy
36,789
+12,677
+53% +$422K 0.01% 654
2020
Q1
$656K Sell
24,112
-13,755
-36% -$374K ﹤0.01% 678
2019
Q4
$747K Sell
37,867
-2,572
-6% -$50.7K ﹤0.01% 906
2019
Q3
$524K Sell
40,439
-1,482
-4% -$19.2K ﹤0.01% 965
2019
Q2
$522K Sell
41,921
-4,956
-11% -$61.7K ﹤0.01% 995
2019
Q1
$681K Buy
46,877
+9,391
+25% +$136K ﹤0.01% 916
2018
Q4
$414K Sell
37,486
-5,817
-13% -$64.2K ﹤0.01% 1017
2018
Q3
$1.14M Sell
43,303
-1,915
-4% -$50.4K 0.01% 776
2018
Q2
$925K Sell
45,218
-2,364
-5% -$48.4K 0.01% 861
2018
Q1
$864K Sell
47,582
-7,117
-13% -$129K 0.01% 885
2017
Q4
$763K Buy
54,699
+5,230
+11% +$73K 0.01% 945
2017
Q3
$915K Buy
49,469
+3,897
+9% +$72.1K 0.01% 759
2017
Q2
$770K Sell
45,572
-1,764
-4% -$29.8K 0.01% 818
2017
Q1
$632K Sell
47,336
-11,445
-19% -$153K 0.01% 927
2016
Q4
$885K Buy
58,781
+6,499
+12% +$97.8K 0.01% 832
2016
Q3
$611K Sell
52,282
-9,873
-16% -$115K 0.01% 870
2016
Q2
$671K Buy
62,155
+2,076
+3% +$22.4K 0.01% 852
2016
Q1
$555K Sell
60,079
-5,853
-9% -$54.1K 0.01% 951
2015
Q4
$978K Buy
65,932
+6,446
+11% +$95.6K 0.01% 745
2015
Q3
$976K Sell
59,486
-3,741
-6% -$61.4K 0.01% 679
2015
Q2
$1.44M Buy
63,227
+8,361
+15% +$191K 0.02% 623
2015
Q1
$834K Buy
54,866
+8,219
+18% +$125K 0.01% 937
2014
Q4
$562K Sell
46,647
-841
-2% -$10.1K 0.01% 1135
2014
Q3
$539K Sell
47,488
-9,799
-17% -$111K 0.01% 1359
2014
Q2
$692K Sell
57,287
-31,672
-36% -$383K 0.01% 1376
2014
Q1
$1.04M Buy
88,959
+62,017
+230% +$722K 0.01% 1281
2013
Q4
$476K Sell
26,942
-22,267
-45% -$393K 0.01% 1075
2013
Q3
$708K Buy
49,209
+7,197
+17% +$104K 0.02% 1156
2013
Q2
$633K Buy
+42,012
New +$633K 0.01% 1142